• Je něco špatně v tomto záznamu ?

Supplementation of l-carnitine during in vitro maturation improves embryo development from less competent bovine oocytes

D. Knitlova, P. Hulinska, M. Jeseta, K. Hanzalova, B. Kempisty, M. Machatkova,

. 2017 ; 102 (-) : 16-22. [pub] 20170705

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033823

The present study was designed to define the impact of l-carnitine, supplemented during maturation, on bovine oocytes with different meiotic competence in terms of their IVF outcomes. Meiotically more competent (MMC) and less competent (MLC) oocytes were obtained separately from differently sized follicles at selected phases of folliculogenesis. The oocytes were matured with or without l-carnitine, fertilized and cultured to the blastocyst stage. The oocytes were examined for nuclear maturation, mitochondrial cluster formation, lipid consumption, fertilization and embryo development. The proportion of oocytes at metaphase II was significantly higher in the l-carnitine-treated MMC than that in the l-carnitine-treated MLC oocytes. However in comparison with the untreated controls, the proportion of MII oocytes with mitochondrial clusters was significantly higher only in the l-carnitine-treated MLC oocytes, which also showed a significantly lower mean lipid content. The l-carnitine-treated MLC oocytes showed significantly higher fertilization and syngamy rates than the untreated MLC oocytes. On the other hand, in the l-carnitine-treated MMC oocytes, the fertilization rate was similar to that of the untreated controls and the syngamy rate was significantly delayed. Although no significant differences in cleavage on Day 2 were found among all oocyte categories, l-carnitine treatment resulted in a significantly higher blastocyst yield in the MLC oocytes on Day 7 and Day 8 and a significantly higher proportion of expanded blastocysts in relation to the total number of blastocysts in MMC oocytes on Day 8. It can be concluded that l-carnitine supplementation during maturation improves the development of bovine embryos from meiotically less competent oocytes and accelerates blastocyst formation from more competent oocytes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033823
003      
CZ-PrNML
005      
20181012092650.0
007      
ta
008      
181008s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.theriogenology.2017.06.025 $2 doi
035    __
$a (PubMed)28719824
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Knitlova, Drahomira $u Department of Genetics and Reproduction, Veterinary Research Institute, Brno, Czech Republic.
245    10
$a Supplementation of l-carnitine during in vitro maturation improves embryo development from less competent bovine oocytes / $c D. Knitlova, P. Hulinska, M. Jeseta, K. Hanzalova, B. Kempisty, M. Machatkova,
520    9_
$a The present study was designed to define the impact of l-carnitine, supplemented during maturation, on bovine oocytes with different meiotic competence in terms of their IVF outcomes. Meiotically more competent (MMC) and less competent (MLC) oocytes were obtained separately from differently sized follicles at selected phases of folliculogenesis. The oocytes were matured with or without l-carnitine, fertilized and cultured to the blastocyst stage. The oocytes were examined for nuclear maturation, mitochondrial cluster formation, lipid consumption, fertilization and embryo development. The proportion of oocytes at metaphase II was significantly higher in the l-carnitine-treated MMC than that in the l-carnitine-treated MLC oocytes. However in comparison with the untreated controls, the proportion of MII oocytes with mitochondrial clusters was significantly higher only in the l-carnitine-treated MLC oocytes, which also showed a significantly lower mean lipid content. The l-carnitine-treated MLC oocytes showed significantly higher fertilization and syngamy rates than the untreated MLC oocytes. On the other hand, in the l-carnitine-treated MMC oocytes, the fertilization rate was similar to that of the untreated controls and the syngamy rate was significantly delayed. Although no significant differences in cleavage on Day 2 were found among all oocyte categories, l-carnitine treatment resulted in a significantly higher blastocyst yield in the MLC oocytes on Day 7 and Day 8 and a significantly higher proportion of expanded blastocysts in relation to the total number of blastocysts in MMC oocytes on Day 8. It can be concluded that l-carnitine supplementation during maturation improves the development of bovine embryos from meiotically less competent oocytes and accelerates blastocyst formation from more competent oocytes.
650    _2
$a zvířata $7 D000818
650    _2
$a karnitin $x aplikace a dávkování $x farmakologie $7 D002331
650    _2
$a skot $x embryologie $7 D002417
650    _2
$a kultivační média $7 D003470
650    _2
$a kultivace embrya $7 D046149
650    _2
$a embryonální vývoj $x fyziologie $7 D047108
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a IVM techniky $x veterinární $7 D059471
650    _2
$a oocyty $x účinky léků $x fyziologie $7 D009865
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hulinska, Pavlina $u Department of Genetics and Reproduction, Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Jeseta, Michal $u Department of Genetics and Reproduction, Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Hanzalova, Katerina $u Department of Genetics and Reproduction, Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Kempisty, Bartosz $u Department of Histology and Embryology, Department of Anatomy, Poznan University of Medical Science, Poznan, Poland.
700    1_
$a Machatkova, Marie $u Department of Genetics and Reproduction, Veterinary Research Institute, Brno, Czech Republic. Electronic address: machatkova@vri.cz.
773    0_
$w MED00004512 $t Theriogenology $x 1879-3231 $g Roč. 102, č. - (2017), s. 16-22
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28719824 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181012093141 $b ABA008
999    __
$a ok $b bmc $g 1340988 $s 1030817
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 102 $c - $d 16-22 $e 20170705 $i 1879-3231 $m Theriogenology $n Theriogenology $x MED00004512
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...